Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 1993
  2. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin

    Schmidt, M., Sorbe, B., T Högberg, Himmelmann, A., Räisänen, I., Stockmeyer, M. & de Bruijn, K. M., 1993, In : Annals of oncology : official journal of the European Society for Medical Oncology. 4 , Suppl 3, p. S31-S34

    Research output: Contribution to journalArticle

  3. 1998
  4. Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience

    Tropé, C., Hogberg, T., Kaern, J., Bertelsen, K., Bjorkholm, E., Boman, K., Himmelmann, A., Horvath, G., Jacobsen, A., Kuoppola, T., Vartianen, J., Lund, B., Onsrud, M., Puistola, U., Salmi, T., Scheistroen, M., Sandvei, R., Simonsen, E., Sorbe, B., Tholander, B. & 1 others, Westberg, R., 1998 Dec, In : Annals of oncology : official journal of the European Society for Medical Oncology. 9, 12, p. 1301-1307 7 p.

    Research output: Contribution to journalArticle

  5. 1999
  6. CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial

    Mats Jerkeman, Anderson, H., Cavallin-Ståhl, E., Michael Dictor, Hagberg, H., Johnson, A., Kaasa, S., Kvaloy, S., Sundstrom, C. & Åkerman, M., 1999, In : Annals of Oncology. 10, 9, p. 1079-1086

    Research output: Contribution to journalArticle

  7. 2000
  8. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

    Tropé, C., Kaern, J., T Hogberg, Abeler, V., Hagen, B., Kristensen, G., Onsrud, M., Pettersen, E., Rosenberg, P., Sandvei, R., Sundfor, K. & Vergote, I., 2000 Mar, In : Annals of oncology : official journal of the European Society for Medical Oncology. 11, 3, p. 281-8 8 p.

    Research output: Contribution to journalArticle

  9. 2001
  10. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation

    Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Saeter, G. & Thor Alvegård, 2001, In : Annals of Oncology. 12, 11, p. 1601-1604

    Research output: Contribution to journalArticle

  11. Neuroendocrine pathogenesis in adenocarcinoma of the prostate

    Jens Ceder & Abrahamsson, P-A., 2001, In : Annals of Oncology. 12, Suppl. 2, p. S145-S152

    Research output: Contribution to journalArticle

  12. 2002
  13. Cancer prevalence in European registry areas

    Micheli, A., Mugno, E., Krogh, V., Quinn, M. J., Coleman, M., Hakulinen, T., Gatta, G., Berrino, F., Capocaccia, R., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 840-865

    Research output: Contribution to journalArticle

  14. Measuring cancer prevalence in Europe: the EUROPREVAL project

    Capocaccia, R., Colonna, M., Corazziari, I., De Angelis, R., Francisci, S., Micheli, A., Mugno, E., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 831-839

    Research output: Contribution to journalArticle

  15. 2003
  16. Cancer prevalence in Northern Europe: the EUROPREVAL study.

    Möller, T., Anderson, H., Aareleid, T., Hakulinen, T., Storm, H., Tryggvadottir, L., Corazziari, I. & Mugno, E., 2003, In : Annals of Oncology. 14, 6, p. 946-957

    Research output: Contribution to journalArticle

  17. 2004
  18. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

    Ferreri, AJM., Campo, E., Arnbrosetti, A., Ilariucci, F., Seymour, JF., Willemze, R., Arrigoni, G., Rossi, G., Lopez-Guillermo, A., Berti, E., Eriksson, M., Federico, M., Cortelazzo, S., Govi, S., Frungillo, N., Dell'Oro, S., Lestani, M., Asioli, S., Pedrinis, E., Ungari, M. & 7 others, Motta, T., Rossi, R., Artusi, T., Iuzzolino, P., Zucca, E., Cavalli, F. & Ponzoni, M., 2004, In : Annals of Oncology. 15, 8, p. 1215-1221

    Research output: Contribution to journalArticle

  19. Colon cancer prevalence and estimation of differing care needs of colon cancer patients

    Gatta, G., Capocaccia, R., Berrino, F., Ruzza, M. R., Contiero, P., Möller, T. & EUROPREVAL Working Group, A. T., 2004, In : Annals of Oncology. 15, 7, p. 1136-1142

    Research output: Contribution to journalArticle

  20. External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years

    Mueller, CR., Ulf Kristoffersson & Stoppa-Lyonnet, D., 2004, In : Annals of Oncology. 15, Suppl. 1, p. I14-I17

    Research output: Contribution to journalArticle

  21. 2005
  22. 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration

    Stuart, G., Avall-Lundqvist, E., du Bois, A., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., Eisenhauer, E., Friedlaender, M., Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Hogberg, T., Kaye, S., Kitchener, H., Kristensen, G., Mannel, R., Meier, W. & 21 others, Miller, B., Oza, A., Ozols, R., Parmar, M., Pfisterer, J., Poveda, A., Provencher, D., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G., Sagae, S., Stehman, F., Trimble, E., Thigpen, T., Vasey, P., Vergote, I., Verheijen, R., Vermorken, J. & Wagner, U., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16, Suppl 8, p. viii36-viii38

    Research output: Contribution to journalArticle

  23. Clinical trials in ovarian carcinoma: study methodology

    Vermorken, J. B., Parmar, M. K. B., Brady, M. F., Eisenhauer, E. A., T Hogberg, Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S. & Verheijen, R. H. M., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16 , Suppl 8, p. viii20-viii29

    Research output: Contribution to journalArticle

  24. 2006
  25. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

    Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J. -O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D. & Ringden, O., 2006, In : Annals of Oncology. 17, 7, p. 1134-1140

    Research output: Contribution to journalArticle

  26. 2007
  27. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

    Bjoerkholm, M., Hagberg, H., Holte, H., Kvaloy, S., Teerenhovi, L., Anderson, H., Cavallin-Ståhl, E., Myhre, J., Pertovaara, H., Oest, A., Nilsson, B. & Oesby, E., 2007, In : Annals of Oncology. 18, 6, p. 1085-1089

    Research output: Contribution to journalArticle

  28. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers

    Vineis, P., Veglia, F., Garte, S., Malaveille, C., Matullo, G., Dunning, A., Peluso, M., Airoldi, L., Overvad, K., Raaschou-Nielsen, O., Clavel-Chapelon, F., Linseisen, J. P., Kaaks, R., Boeing, H., Trichopoulou, A., Palli, D., Crosignani, P., Tumino, R., Panico, S., Bueno-De-Mesquita, H. B. & 15 others, Peeters, P. H., Lund, E., Gonzalez, C. A., Martinez, C., Dorronsor, M., Barricarte, A., Navarro, C., Quiros, J. R., Berglund, G., Jarvholm, B., Day, N. E., Key, T. J., Saracci, R., Riboli, E. & Autrup, H., 2007, In : Annals of Oncology. 18, 7, p. 1230-1242

    Research output: Contribution to journalArticle

  29. Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

    Wilking, N., Lidbrink, E., Wiklund, T., Erikstein, B., Lindman, H., Per Malmström, Kellokumpu-Lehtinen, P., Bengtsson, N. -O., Soederlund, G., Anker, G., Wist, E., Ottosson, S., Salminen, E., Ljungman, P., Holte, H., Nilsson, J., Blomqvist, C. & Bergh, J., 2007, In : Annals of Oncology. 18, 4, p. 694-700

    Research output: Contribution to journalArticle

  30. Targeted therapy in nuclear medicine current status and future prospects

    Oyen, W. J. G., Bodei, L., Giammarile, F., Maecke, H. R., Jan Tennvall, Luster, M. & Brans, B., 2007, In : Annals of Oncology. 18, 11, p. 1782-1792

    Research output: Contribution to journalArticle

  31. Familial blood vessel tumors and subsequent cancers

    J. Ji & K. Hemminki, 2007 Jul 1, In : Annals of Oncology. 18, 7, p. 1260-1267 8 p.

    Research output: Contribution to journalArticle

  32. 2008
  33. a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma

    Dueland, S., Aamdal, S., Nyakas, M., Lundgren, L., Wagenius, G., Ljuslinder, I., Stierner, U., Gaullier, J., Nilsson, B. I. & Rasch, W., 2008, In : Annals of Oncology. 19, p. 245-246

    Research output: Contribution to journalPublished meeting abstract

  34. A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

    Glimelius, B., Sorbye, H., Balteskard, L., Bystrom, P., Pfeiffer, P., Tveit, K., Heikkila, R., Keldsen, N., Albertsson, M., Starkhammar, H., Garmo, H. & Berglund, A., 2008, In : Annals of Oncology. 19, 5, p. 909-914

    Research output: Contribution to journalArticle

  35. BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M., Banham, A., Enblad, G. & Leppa, S., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 142-iv 142

    Research output: Contribution to journalPublished meeting abstract

  36. Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries

    Brown, P. D., Samuelsson, V., d'Amore, F., Lindh, J., Hagberg, H., Nilsson, G., Bernell, P., Pedersen, L. M. & Mats Jerkeman, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 131-iv 131

    Research output: Contribution to journalPublished meeting abstract

  37. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

    Crusius, J. B. A., Canzian, F., Capella, G., Pena, A. S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H. B., Carneiro, F., Pala, V., Save, V. E., Vineis, P., Tumino, R., Panico, S., Berglund, G. & 27 others, Manjer, J., Stenling, R., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjonneland, A., Buechner, F. C., Peeters, P. H. M., Numans, M. E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E. & Gonzalez, C. A., 2008, In : Annals of Oncology. 19, 11, p. 1894-1902

    Research output: Contribution to journalArticle

  38. Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden

    Kristinsson, S. Y., Bjorkholm, M., Goldin, L. R., McMaster, M. L., Ingemar Turesson & Landgren, O., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 166-iv 166

    Research output: Contribution to journalPublished meeting abstract

  39. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    Aapro, M., Abrahamsson, P-A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F. & Thürlimann, B., 2008, In : Annals of Oncology. 19, 3, p. 420-432

    Research output: Contribution to journalArticle

  40. Mature T-cell lymphoma patients show high relapse rates after high dose therapy followed by autologous transplantation

    Nickelsen, M., Canals, C., Schmitz, N., Glass, B., Leyvraz, S., Engelhard, M., Koza, V., Relander, T., Holowiecki, J., Linkesch, W., Losonczy, H., Meloni, G., Briones, J. & Sureda, A., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 113-iv 114

    Research output: Contribution to journalPublished meeting abstract

  41. Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis

    Lindman, H., Ostri, P., Andersen, M., Hagen, E. K., Wiklund, K. & Abrahamsson, P-A., 2008, In : Annals of Oncology. 19, p. 255-255

    Research output: Contribution to journalPublished meeting abstract

  42. Self-selection in sigmoidoscopy screening: A nine-year follow-up study

    Blom, J., Yin, L., Liden, A., Dolk, A., Bengt Jeppsson, Pahlman, L., Holmberg, L. & Nyren, O., 2008, In : Annals of Oncology. 19, Suppl. 6, p. 101-102

    Research output: Contribution to journalPublished meeting abstract

  43. Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma

    Michael Dictor, Sara Ek, Mats Jerkeman, Karin Jirström & Carl Borrebaeck, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 172-iv 173

    Research output: Contribution to journalPublished meeting abstract

  44. Transformed diffuse large B cell lymphomas differ from follicular lymphomas in both gene and protein expression

    Ulrika Andreasson, Michael Dictor, Mats Jerkeman, Rosenquist, R., Carl Borrebaeck & Sara Ek, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 111-iv 111

    Research output: Contribution to journalPublished meeting abstract

  45. 2009
  46. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden

    J. Ji, Shu, X., Li, X., Kristina Sundquist, Sundquist, J. & Hemminki, K., 2009, In : Annals of Oncology. 20, 6, p. 1121-1126

    Research output: Contribution to journalArticle

  47. DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT

    Dolan, R. T., Brennan, D. J., Rexhepaj, E., Kelly, C. M., Penny, S., Karin Jirström, Ponten, F., Uhlen, M. & Gallagher, W. M., 2009, In : Annals of Oncology. 20, Suppl 2, p. 54-54

    Research output: Contribution to journalPublished meeting abstract

  48. Empirically derived psychosocial states among adolescents diagnosed with cancer during the acute and extended phase of survival

    Mattsson, E., El-Khouri, B., Ljungman, G. & von Essen, L., 2009, In : Annals of Oncology. 20, 10, p. 1722-1727

    Research output: Contribution to journalArticle

  49. IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH

    Ostman, A., Augsten, M., Hagglof, C., Bruzzese, F., Leone, A., Olsson, E., Åke Borg, Egevad, L. & Micke, P., 2009, In : Annals of Oncology. 20, Suppl 3, p. O34-O34

    Research output: Contribution to journalPublished meeting abstract

  50. 2010
  51. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  52. Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours

    Blay, J., Le Cesne, A., Judson, I., Schoffski, P., Sessa, C., Paz-Ares, L., Thomas Högberg, Zintl, P., Parekh, T. V. & Demetri, G. D., 2010, In : Annals of Oncology. 21, Suppl. 8, p. 177-178

    Research output: Contribution to journalPublished meeting abstract

  53. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

    O'Day, S. J., Maio, M., Chiarion-Sileni, V., Gajewski, T. F., Pehamberger, H., Bondarenko, I. N., Queirolo, P., Lundgren, L., Mikhailov, S., Roman, L., Verschraegen, C., Humphrey, R., Ibrahim, R., de Pril, V., Hoos, A. & Wolchok, J. D., 2010, In : Annals of Oncology. 21, 8, p. 1712-1717

    Research output: Contribution to journalArticle

  54. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

    Tandstad, T., Cohn-Cedermark, G., Dahl, O., Stierner, U., Cavallin-Ståhl, E., Bremnes, R. M. & Klepp, O., 2010, In : Annals of Oncology. 21, 9, p. 1858-1863

    Research output: Contribution to journalArticle

  55. Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

    Morschhauser, F., Marlton, P., Vitolo, U., Lindén, O., Seymour, J. F., Crump, M., Coiffier, B., Foa, R., Wassner, E., Burger, H. -U., Brennan, B. & Mendila, M., 2010, In : Annals of Oncology. 21, 9, p. 1870-1876

    Research output: Contribution to journalArticle

  56. Second cancers after testicular cancer diagnosed after 1980 in Sweden

    Kari Hemminki, Liu, H. & Jan Sundquist, 2010, In : Annals of Oncology. 21, 7, p. 1546-1551

    Research output: Contribution to journalArticle

  57. STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE

    Ostman, A., Paulsson, J., Liu, T., Lisa Rydén, Karin Jirström, Landberg, G. & Bergh, J., 2010, In : Annals of Oncology. 21, p. 115P

    Research output: Contribution to journalPublished meeting abstract

  58. Vandetanib In Locally Advanced Or Metastatic Differentiated Thyroid Cancer (Papillary Or Follicular; Dtc): A Randomized, Double-Blind Phase Ii Trial

    Leboulleux, S., Bastholt, L., Krause, T. M., De La Fouchardiere, C., Jan Tennvall, Awada, A., Gomez, J. M., Carrasco, A. T., Licour, M. & Schlumberger, M. J., 2010, In : Annals of Oncology. 21, p. 315-315

    Research output: Contribution to journalPublished meeting abstract

  59. 2011
  60. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)

    Nagel, G., Concin, H., Bjorge, T., Rapp, K., Jonas Manjer, Hallmans, G., Diem, G., Haggstrom, C., Engeland, A., Martin Almquist, Jonsson, H., Selmer, R., T. Stocks, Tretli, S., Ulmer, H., Stattin, P. & Lukanova, A., 2011, In : Annals of Oncology. 22, 6, p. 1339-1345

    Research output: Contribution to journalArticle

  61. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Thomas Wiebe, Fagioli, F., Thor Alvegård, del Prever, A. B., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G. & Smeland, S., 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  62. 2012
  63. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

Previous 1 2 3 Next